These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18727600)

  • 1. [Treatment of hypertension in people over 80 years should not be discontinued].
    Thien T; Deinum J
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1713-6. PubMed ID: 18727600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Older age should not be a barrier to the treatment of hypertension.
    Aronow WS
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.
    Beckett N; Peters R; Tuomilehto J; Swift C; Sever P; Potter J; McCormack T; Forette F; Gil-Extremera B; Dumitrascu D; Staessen JA; Thijs L; Fletcher A; Bulpitt C;
    BMJ; 2011 Jan; 344():d7541. PubMed ID: 22218098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy in treating the oldest old with hypertension: is the hypertension in the very elderly trial the final answer?
    Abramov D; Cheng H
    J Am Geriatr Soc; 2009 Mar; 57(3):570-1. PubMed ID: 19278408
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
    Bulpitt CJ; Beckett NS; Peters R; Leonetti G; Gergova V; Fagard R; Burch LA; Banya W; Fletcher AE
    J Hum Hypertens; 2012 Mar; 26(3):157-63. PubMed ID: 21390056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
    Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
    Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension in the very elderly: Brief review of management.
    Zeglin MA; Pacos J; Bisognano JD
    Cardiol J; 2009; 16(4):379-85. PubMed ID: 19653187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypertension in patients 80 years of age or older.
    Beckett NS; Peters R; Fletcher AE; Staessen JA; Liu L; Dumitrascu D; Stoyanovsky V; Antikainen RL; Nikitin Y; Anderson C; Belhani A; Forette F; Rajkumar C; Thijs L; Banya W; Bulpitt CJ;
    N Engl J Med; 2008 May; 358(18):1887-98. PubMed ID: 18378519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET).
    Bulpitt CJ; Beckett NS; Peters R; Banya W; Liu L; Wang JG; Stoyanovsky V; Dumitrascu D; Nikitin Y; Staessen JA; Burch L; Fletcher AE
    Blood Press; 2009; 18(1-2):17-22. PubMed ID: 19353407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).
    Peters R; Pinto E; Beckett N; Swift C; Potter J; McCormack T; Nunes M; Grimley-Evans J; Fletcher A; Bulpitt C
    Age Ageing; 2010 Jul; 39(4):439-45. PubMed ID: 20497949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of arterial hypertension in octogenarian].
    Pepersack T; De Breucker S; Thomas JM
    Rev Med Brux; 2006; 27(2):84-8. PubMed ID: 16736845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
    Du X; Ninomiya T; de Galan B; Abadir E; Chalmers J; Pillai A; Woodward M; Cooper M; Harrap S; Hamet P; Poulter N; Lip GY; Patel A;
    Eur Heart J; 2009 May; 30(9):1128-35. PubMed ID: 19282274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension in the elderly.
    Aronow WS
    Geriatrics; 2008 Oct; 63(10):21-5. PubMed ID: 18828653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
    Bulpitt C; Fletcher A; Beckett N; Coope J; Gil-Extremera B; Forette F; Nachev C; Potter J; Sever P; Staessen J; Swift C; Tuomilehto J
    Drugs Aging; 2001; 18(3):151-64. PubMed ID: 11302283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination perindopril/indapamide for the treatment of hypertension: a review.
    de Leeuw PW
    Expert Opin Pharmacother; 2011 Aug; 12(11):1827-33. PubMed ID: 21651456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
    Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML
    Eur Heart J; 2009 Jun; 30(11):1385-94. PubMed ID: 19346520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.